Objectives: To explore the association of the postthrombotic syndrome with venous hemodynamics and morphological abnormalities after upper extremity deep venous thrombosis. Methods: Thirty-seven patients with a history of upper extremity deep venous thrombosis treated with anticoagulation alone underwent a single study visit (mean time after diagnosis: 44.4 AE 28.1 months). Presence and severity postthrombotic syndrome were classified according to the modified Villalta score. Venous volume and venous emptying were determined by strain-gauge plethysmography. The arm veins were assessed for postthrombotic abnormalities by ultrasonography. The relationship between postthrombotic syndrome and hemodynamic and morphological sequelae was evaluated using univariate significance tests and Spearman's correlation analysis. Results: Fifteen of 37 patients (40.5%) developed postthrombotic syndrome. Venous volume and venous emptying of the arm affected by upper extremity deep venous thrombosis did not correlate with the Villalta score (rho ¼ 0.17 and 0.19; p ¼ 0.31 and 0.25, respectively). Residual morphological abnormalities, as assessed by ultrasonography, did not differ significantly between patients with and without postthrombotic syndrome (77.3% vs. 86.7%, p ¼ 0.68). Conclusions: Postthrombotic syndrome after upper extremity deep venous thrombosis is not associated with venous hemodynamics or residual morphological abnormalities.
Introduction
Upper extremity deep venous thrombosis (UEDVT) accounts for up to 11% of all cases of deep venous thrombosis. 1 While primary UEDVT occurs without apparent risk factors (idiopathic UEDVT) or after strenuous exercise of the upper extremities (Paget-von Schroetter syndrome), secondary UEDVT is a consequence of clinically apparent risk factors, predominantly cancer and indwelling central venous catheters. 2 The cornerstone of UEDVT treatment is anticoagulation. 3 Although the clinical benefit is unclear, many authors advocate additional treatment with thrombolysis with or without a staged interventional or surgical approach, aiming to restore venous patency and to prevent the postthrombotic syndrome (PTS). 4, 5 This concept implies a correlation between the presence of morphological and hemodynamic abnormalities after UEDVT with the clinical outcome, i.e. the PTS. However, literature provides only scarce and in part conflicting data on this correlation. [6] [7] [8] [9] Against this background, we aimed to determine the association between PTS, residual morphological vein alterations as determined by ultrasonography and venous function as assessed by strain-gauge plethysmography in a cohort of patients with UEDVT treated with anticoagulation alone.
Patients and methods
Patients who were first diagnosed with UEDVT at our institution between 1999 and 2008 were retrospectively identified from an electronic database and invited for a single study visit. Patients were eligible for the study if they had a history of a first, symptomatic UEDVT involving the subclavian, axillary and/or brachial veins that was objectively confirmed by ultrasonography and was treated conservatively. Subjects who had undergone interventional treatment (i.e. thrombolysis, angioplasty with stenting and/or surgical decompression of the thoracic outlet) were excluded. A minimal time interval of 6 months was required to be elapsed between diagnosis and the study visit. 10 The study protocol was approved by the local ethics committee, and patients gave written informed consent.
Information on demographic characteristics, risk factors for UEDVT, affected venous segments and treatment duration were recorded. Assessment of the character and severity of venous symptoms of the affected arm was performed using a validated PTSscale adapted to the upper extremities (modified Villalta score). [8] [9] [10] [11] [12] The scale consists of 11 items, 5 of which are symptoms rated subjectively by the patient. Six items are clinical signs evaluated by the physician (Table 1) . Every item is graded on a scale from 0 (absent) to 3 (severe), with a maximum overall score of 33. A score below 5 is classified as no PTS, a score of 5-14 is classified as mild to moderate PTS and a score between 15 and 33 is classified as severe PTS.
Venous plethysmography was performed by one of the authors (S.P.) using the Vasolab 5000 system (ELCAT GmbH, Wolfratshausen, Germany). The plethysmographic examinations were done with the patient in a supine position and the arms resting in an elevated position at the level of the shoulder. Tourniquets were placed on each upper arm, and strain-gauge wires were placed on each forearm. Venous volume (ml/100 ml) was measured as the maximal volume changes after occluding the brachial veins for 3 min by inflation of the arm cuffs to a pressure of 60 mmHg. Venous emptying (ml/100 ml/min) was determined as the rate of volume outflow within one second after release of the venous occlusion. 9 Lower normal limits of 3 ml/100 ml for venous volume and 68 ml/100 ml/min for venous emptying were applied as reference values. 9, 13 Both values were calculated as mean values from three repeated measurements.
All sonographic examinations were performed by an experienced Vascular Medicine specialist (A.R.), using the LOGIC TM 9 (General Electric Medical Systems, Milwaukee, Wisconsin, USA) ultrasound device with a 5-10 MHz linear transducer. The brachiocephalic, subclavian, axillary, brachial, internal jugular, cephalic and basilic vein were visualized using the B-mode (with and without vein compression) and the pulsed wave and colour-duplex mode. Venous morphology and flow in the subclavian vein were analyzed with the patient in a supine position and the arm slightly abducted. Venous segments were categorized in (a) normal vein, (b) abnormal vein with residual thrombus or residual postthrombotic wall thickening but visible blood flow and (c) completely occluded vein. Valvular patency was assessed in the brachial, cephalic and basilic vein with the patient in an upright sitting position and the arm hanging down. Venous reflux was provoked by distal manual compression, and a duration of the venous reflux of more than 0.5 s was considered to be pathological. 13 Statistical analysis was performed using the R software for statistical computing (R Development Core Team, Vienna, Austria). Results for categorical variables are presented as frequency (in percent), and continuous variables are displayed as mean AE standard deviation. Univariate comparisons between two groups were performed using Fisher's exact test (categorical variables) and Mann-Whitney U-test (continuous variables). In the case of paired samples, the McNemar test (categorical variables) and the Wilcoxon test (continuous variables) for paired samples were applied. For univariate comparison of continuous variables between more than two groups, the Kruskal-Wallis rank sum test was applied. Twosided p-values < 0.05 were considered significant. Spearman's correlation analysis was used to explore the relationship between the Villalta score and hemodynamic parameters (venous volume and venous emptying) and between the Villalta score and the time between diagnosis and the study visit, respectively.
Results

Patient characteristics
Fifty-eight patients were identified of whom 37 patients could be included in the study, all of them having a history of a first episode of objectively verified unilateral UEDVT. Twenty-one patients were not included because of patient's death or inability to contact the patient (11 patients), refusal to take part in the study (9 patients) and interventional treatment of UEDVT with thrombolysis and angioplasty (1 patient). The clinical characteristics of the 37 study subjects are shown in Table 2 . The demographic data of the 25 patients with primary UEDVT have been published previously. 12 Within the subgroup of 12 patients with secondary UEDVT, 6 patients suffered from catheter-associated thrombosis (4 patients with malignancy and port catheters and 2 patients with central venous catheters during critical illness), 2 patients had local venous compression due to lymphoma, 2 patients had undergone osteosynthesis of a clavicle fracture, 1 patient had thrombosis after implantation of pacemaker leads and 1 patient was diagnosed with antiphospholipid antibody syndrome. Diagnosis of UEDVT was initially confirmed by ultrasonography in all patients. Additional imaging methods (computed tomography, venography) contributed to the diagnosis in 7 of 37 patients (18.9%). The subclavian, axillary and brachial veins were involved in 97.3%, 32.4% and 5.4%, respectively. The brachiocephalic and internal jugular veins were additionally affected in 10.8% and 17.9% of patients, respectively. Involvement of the basilic vein was noticed in two patients. Two or more venous segments were affected in 45.9% of patients. Subjects with secondary UEDVT tended to have more frequent involvement of more than one venous segment (58.3% vs. 40%, p ¼ 0.48).
The mean duration of anticoagulation was 5.6 AE 11.5 months, and the mean interval between diagnosis and the study visit was 44.4 AE 28.1 months (minimum 6 months, maximum 115 months). None of the patients had developed symptomatic recurrent UEDVT or symptomatic pulmonary embolism until the follow-up visit.
Postthrombotic syndrome
According to the modified Villalta score, the following signs and symptoms of the arm affected by UEDVT were present at the follow-up visit: dilated subcutaneous collateral veins (73.0%), heaviness (59.5%), paresthesia (51.4%), pain (43.2%), intermittent swelling (37.8%), redness or cyanosis (21.6%), pruritus (18.9%) and cramps (13.5%). Symptoms at the contralateral arm were not reported by any of the patients.
The mean Villalta score was 5.0 AE 4.2 and did not differ significantly between patients with secondary UEDVT compared to those with primary UEDVT (6.5 AE 4.7 vs. 4.2 AE 3.8, p ¼ 0.14). Of note, the Villaltascore did not correlate with the time interval between diagnosis and the study visit (Spearman's rho 0.15, p ¼ 0.39). Fourteen out of the 37 patients (37.8%) suffered from mild to moderate PTS, but only one patient with secondary UEDVT met the criteria for severe PTS. Venous ulceration did not occur. Patients with secondary UEDVT more frequently suffered from PTS although this difference was not statistically significant (58.3% vs. 32.0%, p ¼ 0.16). The frequency of PTS did not differ with regard to occupation (physically 
Venous hemodynamics
The mean values for venous emptying and venous volume are listed in Table 3 . There were no significant differences between the arm affected by thrombosis and the contralateral arm with respect to venous volume and venous emptying. The percentage of patients with venous volume and venous emptying below the lower normal limit did not differ significantly between the arm 0.25, respectively) . Surprisingly, patients with PTS exhibited a higher-mean venous volume and venous emptying of the arm affected as compared with patients without PTS. However, differences reached significance for venous emptying only (p ¼ 0.03, Table 3 , Figure 1 ). The percentage of patients with venous volume or venous emptying below the lower normal limit did not differ significantly between patients with PTS and those without PTS (venous volume: 46.7% vs. 45.5%, p ¼ 1.0; venous emptying: 46.7% vs. 68.2%, p ¼ 0.49).
Venous morphology and valvular function
Follow-up ultrasonography showed normal venous morphology in 7 patients (18.9%), whereas 21 patients (56.8%) exhibited residual postthrombotic changes and 9 (24.3%) had complete venous occlusion. Mean venous volume and venous emptying were not significantly different in postthrombotic extremities with either sonographically normal, abnormal or occluded deep veins (venous volume: p ¼ 0.38; venous emptying: p ¼ 0.48; Table 3 , Figure 2 ). The Villalta score was not different in the three sonographic categories (p ¼ 0.32; Figure 3 ). Residual morphological abnormalities (wall thickening, residual thrombosis or occlusion) were not found to be more common in patients with PTS than in patients without PTS (77.3% vs. 86.7%, p ¼ 0.68). The number of venous segments affected initially and at the follow-up visit, respectively, did not correlate with venous hemodynamics and the clinical outcome in terms of the PTS (data not shown). Valvular dysfunction in terms of deep or superficial venous reflux was not found in any of the patients.
Discussion
In the present study on 37 patients with a history of UEDVT treated with anticoagulation alone, we assessed the correlation between morphological and hemodynamic parameters and the occurrence of the PTS after a mean follow up of almost 4 years. Our study did not show any significant association between morphological (postthrombotic changes assessed by ultrasonography) and hemodynamic parameters (venous volume and venous emptying assessed by venous plethysmography) in the arm affected by UEDVT. Most importantly, both venous hemodynamics and venous morphology were not correlated to the presence of PTS, which occurred in 40.5% of our patients.
Persson et al. 9 previously investigated the correlation of venous volume and venous emptying with the occurrence of PTS in subjects with a history of UEDVT. In agreement with our findings, the authors 9 were also not able to show an association between venous hemodynamics and the clinical outcome (PTS). The fact that, in our cohort, venous hemodynamics did not differ significantly between the arm affected by UEDVT, and the contralateral arm may indicate an excellent venous collateralization particularly in patients with residual venous obstructions.
Few studies reported on the correlation between morphological sequelae of UEDVT, as determined by ultrasonography, and the occurrence of PTS. While Prandoni et al. 8 documented a significantly increased risk of PTS in patients exhibiting residual thrombosis, others did not find an association between the presence of postthrombotic vein alterations depicted by ultrasonography and the frequency of PTS. 6 Moreover, in a large retrospective study, Sabeti et al. documented a markedly improved venous patency after systemic thrombolysis compared to anticoagulation alone, but found no difference in the occurrence of PTS between both treatment groups. These results fit well to the findings of our study, as we did not observe any significant differences in the frequency of PTS in patients with normal, abnormal and occluded veins. Vice versa, the frequency of residual morphological abnormalities was similar (about 80%) in our patients with and without PTS.
Taking the currently available evidence together, neither venous plethysmography nor ultrasonography allow the prediction of the clinical outcome after UEDVT in terms of the PTS. Whether other diagnostic methods may be more appropriate in this clinical setting, for instance by visualizing the collateral system or by measuring other parameters of venous insufficiency (e.g. arm volumetry and skin thickness) remains to be investigated. In addition, our findings put a question mark behind the often advocated treatment strategy of restoring venous patency with thrombolysis or with staged multidisciplinary approaches after UEDVT for the prevention of PTS. 4, 5 Although several authors have reported good to excellent success of thrombolytic therapy in terms of early and late venous patency, it is actually unknown whether thrombolytic treatment reduces the incidence of the PTS and improves the clinical outcome after UEDVT. 2, 3, 14 Due to the varying criteria applied for classification of PTS and the differences in the patient populations investigated, the frequency of PTS in patients with conservatively treated UEDVT varied in previous studies within a wide range from 7 to 46%. 14 Studies applying the modified Villalta score, including our study, reported more consistent prevalence rates of PTS between 27 and 41%. [8] [9] [10] 12 Whether primary versus secondary UEDVT is associated with different rates of PTS is unclear. We found a trend towards a higher rate of PTS in patients with secondary UEDVT compared to primary UEDVT. The limited literature available suggests that PTS may occur less frequently after catheter-associated UEDVT. 14 By contrast to Kahn and coworkers, we did not observe a higher frequency of PTS in patients suffering from UEDVT of the dominant versus the non-dominant arm. 9, 12 
